MONA - 400% in nur 5 Tagen

...ich denke, das war ein Schreib-, Tipp-, oder Eingabefehler; Fantompreis, also! Die heutigen -30% aber bittere Realität...  

News: MonArc Corporation (MONA:PK) ITI Bio Tech Creditor

MONTREAL, Jan 07, 2009 /PRNewswire-FirstCall via COMTEX/ -- MonArc Corporation http://www.monacorporation.com/ (MONA.PK) agents having met with principals of ITI Bio Tech have reviewed the ITI's physical plant, equipment operations and inventory. The company is satisfied and will proceed with the merger in a 2 step format.

First step will involve MONA assuming the secured creditor position and by paying out the existing bank notes. This step is scheduled to be finalized today before 5pm. At that point MONA will become a secured creditor. Approximately 7-10 days later, upon receiving clearances from its legal advisors, MONA intends to complete the 2nd stage of its transaction by merging with ITI.

Mr. Sam Grinfield of SG Consulting said, "The ITI company was a hairs breath away from landing some major retail contracts and signing up some significant deals. It simply ran out of gas before the finish line. MONA came in at the right time at the right place. Once all the dust settles and ITI resumes operations we are confident that most of not all of these deals will come to fruition. We would be delighted to welcome any MONA shareholder to visit us and see ITI's operations and infrastructure here in Montreal. They will be pleasantly impressed with the product line of ITI and proud to be a MONA shareholder and to be part of the company."  

MonArc Corporation (MONA:PK) 500 hectare property

PIURA, Peru, Jan 09, 2009 /PRNewswire-FirstCall via COMTEX/ -- MonArc Corporation http://www.monacorporation.com/ (MONA.PK) The company is pleased to announce that it claimed through the Peruvian mining ministry, a 500 hectare property that was available for gold exploration and production. The paper work will take a month before Andrea Gold obtains the legal title on the mining property. This area where local miners get ore from the surface is highly promising due to the high gold grades the locals are obtaining from the ore. The company plans to start immediately on an exploration plan to target some good areas where we could develop a mine and get some ore production going on.
In the processing plant, the company continues to process 40-50 t/d ore and tailings as well from the local miners with an average grade of 10 g/t Au with a weekly gold production of 3 Kl.

Safe Harbour statement under the Private Securities Litigation Reform Act of 1995: Certain forward information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.  

MonArc Corporation (MONA) ITI Bio Tech Merger and Update

MONTREAL, Jan 21, 2009 /PRNewswire-FirstCall via COMTEX/ -- MonArc Corporation http://www.monacorporation.com/ (MONA.PK) further to the company news release of January 7 2009 Mon Arc is set to merge with ITI Bio Tech. I.T.I. CEO Mr. Paul Sylvestre said "The company having moved into its new facility (see Pink Sheets Filings) is preparing as quickly as possible as we begin production for deliveries due to be shipped out at the end of the month".
Mr. Sam Grinfield of SG Consulting said, "As I mentioned before and this is worth repeating, the ITI company was a hair's breath away from landing some major retail contracts and signing up some significant deals. MONA came in at the right time at the right place. As it stands today, MONA is a creditor of ITI however we are working very closely towards completing the merger with MONA possibly as soon as the month's end (January). I believe that the market will soon realize the great potential ITI brings to MONA and its shareholders."

In other corporate news, the company intends to split off its PP365.Com software division on all cash basis. The details will be made available shortly.

Safe Harbour statement under the Private Securities Litigation Reform Act of 1995: Certain forward information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.

CONTACT: corporate@monacorporation.com

SOURCE MonArc Corporation (MONA)  

MonArc Corporation (MONA:PK) Closes Acquisition of I.T.I. Biotech International, Inc.

MONTREAL, Jan 27, 2009 /PRNewswire-FirstCall via COMTEX/ -- Mon Arc Corporation (www.monacorporation.com - MONA.PK) is pleased to announce that it has closed the acquisition of I.T.I. Biotech International, Inc. The Company becomes a wholly owned subsidiary of MonArc, based on an all-stock transaction valued at $500,000 USD at a significantly higher strike price than what MONA is currently trading at (see filings on Pink Sheets).
In a related move, Paul Sylvestre, President of I.T.I. Bio-Tech www.itilaval.com has been appointed CEO of MonArc Corporation.

ITI is a Bio-Tech company, specializing in the manufacturing of products Eliminating Airborne Volatile Organic Compounds (VOC'S). Considered a factor in indoor air quality issues such as sick building syndrome, VOCs are generated by photocopiers, carpets, and furnishings as they are used or when components oxidize.... One irritant, formaldehyde, is present in hundreds of office components, including wood and laminated furniture, shelving, and wall covers. It also evaporates from paints, varnishes, and chemicals used for sealing and finishing walls. Tobacco smoke can also contribute high levels of VOCs.

Products manufactured by ITI are laboratory tested, laboratory certified, biodegradable, food grade approved chemicals, natural scents. These products use recyclable containers, perforated caps to ensure safety of children and pets and are environmentally safe to protect the well being of both people and the planet.

Incoming CEO Sylvestre commented, "We are excited about this significant step forward. We have a lot of product in the pipeline, and we will be making a series of announcements in the coming weeks. We expect to be able to announce new sales contracts as well as significant product developments including testing and approval of new products that are now ready to go to market."

Safe Harbour statement under the Private Securities Litigation Reform Act of 1995: Certain forward information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.  

Infusion of New Capital to Triple Production at MonArc Corporation (MONA:PK) I.T.I. Bio-Tech Subsidiary.
MONTREAL, Jan. 29 /PRNewswire-FirstCall/ - ITI Biotech International, Inc., a wholly owned subsidiary of MonArc Corporation, announced today that the recently negotiated infusion of capital will enable the Company to significantly expand its operations.

Paul Sylvestre, President of I.T.I. Bio-Tech., and incoming CEO of MonArc Corporation noted; 'We expect to triple our production and sales in the first quarter with Monarc by our side. We are grateful to our faithful clientele which has stood by us and continued to order our products, and look forward to making some new product development announcements in the very near future.'


About I.T.I. Bio-Tech,


ITI is a Bio-Tech company, specializing in the manufacturing of products eliminating Airborne Volatile Organic Compounds (VOC'S). Products manufactured by ITI are laboratory tested, laboratory certified, biodegradable, food grade approved chemicals, natural scents. Using recyclable containers, perforated caps to ensure safety of children and pets and environmentally safe for the well being of the people and planet.  

I.T.I. Bio-Tech (MONA:PK) Announces New Product That Combats C-Difficile and Airborne Viruses
MONTREAL, Feb. 2 /PRNewswire-FirstCall/ - ITI Biotech International, Inc., a wholly owned subsidiary of MonArc Corporation, announced today it has begun manufacturing a revolutionary gel paste product that effectively neutralizes and destroys Airborne viruses.

The product works much like a traditional room deodorizer, wherein the gel paste evaporates gradually from within a dispenser placed in the room.

The new product, with a microbial agent added, has been extensively tested in the laboratory and proven 99.8% efficient such viruses as; Staphylococus (ATCC 6538); Pseudomonas aerugin osa (ATCC 15442); and Clostridium difficile (BMS).

Life threatening airborne viruses are a major concern in settings such as hospitals and nursing homes, and it has become standard practice to encourage pro-active measures to address these increased risks, such as having patients and visitors wash their hands when entering and leaving these facilities. The Company's new product adds another important tool to safeguard the health of the population in these settings.

Paul Sylvestre, President of I.T.I. Bio-Tech, and MonArc CEO advised; 'The new product can not only help eliminate these threats, but we anticipate it has the potential to save lives. We will be manufacturing the new product for hospitals, schools, as well as for residential homes. This unique product truly breaks new ground in protecting public health'.

In other Company news, the Company is pleased to announce that the rescission of the Andrea Gold acquisition and spin-off of remaining Chinese assets currently nearing completion, approximately 2 billion shares will be returned by these parties and retired to treasury.


About I.T.I. Bio-Tech,


ITI is a Bio-Tech company, specializing in the manufacturing of products eliminating Airborne Volatile Organic Compounds (VOC'S). Products manufactured by ITI are laboratory tested, laboratory certified, biodegradable, food grade approved chemicals, natural scents. Using recyclable containers, perforated caps to ensure safety of children and pets and environmentally safe for the well being of the people and planet.


Safe Harbour statement under the Private Securities Litigation Reform Act of 1995: Certain forward information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.  

Mon Arc (MONA) Various Corporate Update And Multiple Dividend Distributions (LDSR), (GLCC) and (RMDM)
MONTREAL, Feb. 6 /PRNewswire-FirstCall/ - www.monacorporation.com - The Company (MONA) has been receiving a very high volume of investor enquiries regarding the status of dividends that have been previously announced. Investors should note that all of the dividends previously announced are still forthcoming, but there have been unforeseen delays in processing and executing the distribution of these dividends, which are beyond the control of the company.

Many of the delays that have been encountered relate to the complexity of calculating the quantity of shares or cash amounts to be distributed and determining the accuracy of the distribution to shareholders entitled to receive them. The company's transfer agency has been working diligently with the various regulatory bodies to ensure that these distributions are handled in a manner that can reliably verify the accuracy of the distribution process. The fact that a number of these dividends require the identification of shareholders at a previous point in time, and verification that qualifying shareholders have held shares continuously between the Date of Record and the ex-dividend date as announced, have led to some unanticipated difficulties. Until these are resolved to the satisfaction of all regulatory parties, the dividends cannot be distributed. Moreover the company is still to receive some of these as payment in order to make a distribution.


   The dividends in question include the following:

   1.  A cash dividend declared on October 7, 2008, of $0.20 per share is to
       be paid to shareholders who have held their shares continuously since
       September 30th, 2005. A certain provision excludes payment to
       management, insiders, and founders of MonArc Group, adding to the
       complexity of the calculations. This cash dividend was allocated and
       designated to shareholders who invested in the company in 2005 when
       the company's operations were crippled by the 4 consecutive
       hurricanes which effected the company's operations while it was
       located in Florida.
   2.  Each qualified share of MONA will receive 0.123 shares of Emerald
       stock in respect of the spin-off of Sino Medica into the Emerald
       Capital Group (3EM Frankfurt Exchange). The dividend is to be paid to
       shareholders of record as of February 1, 2008. It is MonArc
       managements understanding that this company is in the process of
       being moved to Pink Sheets from Frankfurt.
   3.  A stock dividend of 0.0026 shares of Landstar Corporation (LDSR) for
       each share of MonArc Corporation will be distributed to shareholders
       of record as of February 1, 2008 in respect of the MonArc Group
       interest of a spin-off of Hubei Chuguan Industry Co. Ltd. to Landstar
       in December, 2008.
   4.  A stock dividend of shares of RMD Entertainment, Inc. (RMDM) shares
       will be distributed in respect of the spin-off of Beijing Innotrek
       Technology Co. Ltd. into RMD Entertainment in October, 2008. A total
       of 2.4 shares of RMD Entertainment (RMDM) will be distributed for
       each share of MonArc Corporation held on the date of record of
       October 16, 2008. The total number of shares anticipated to be
       distributed is approximately 1,000,000,000. MonArc has not received
       these shares yet as this company is in the process of obtaining a new
       CUSIP number and a new trading symbol including a stock reverse. MONA
       agents are currently in China discussing various options available to
       both companies. One option under consideration may involve a post
       reverse stock distribution and another where MONA would in a capacity
       as a shareholder only acquire and keep acquiring RMDM shares on the
       open market. The company sees this as a win win for all concerned and
       its recommendations are under review by the RMDM management and its
       legal advisors.


The Company is working to ensure that problems with the previous stock dividend of shares of Good Life China Corporation (GLCC) are not repeated. The management sub come to the shareholders pressure to issue these dividends, did so prematurely with the restrictive legend attached 'restricted shares'. In the case of the GLCC stock dividend, many shareholders had their shares directed to their brokerage houses, who in turn as we are advised, recorded the shares under the fictitious ticker symbol 'GOLIF' in order to identify them as restricted shares. The Company has been advised by many of its shareholders that there have been difficulties with this distribution, as the brokerage houses in question are requiring a legal opinion from each shareholder attesting to the fact that the shares can have their restrictive legends removed be provided by each individual shareholder. The company has also learned that Good Life China management franticly tried to recall the dividend as it learned that some of the recipients received their stock as free trading from their brokers, which eroded much of their values on relatively small trades. The management does not intend to make the same mistake again.

To address this issue, the Company will be holding the upcoming share dividends in escrow, until they are satisfactorily aged, and allowed to be distributed as free trading shares under the SEC rules and regulations, with the legal opinion letter attached when distributed to the brokers.

The Company is optimistic that the complications encountered in providing sufficient verification regarding the accuracy of these distributions is close to being resolved, and will be providing updates on developments on a timely basis. The company verily believes that this dividend calculation difficulty is further compounded by the extreme shorting which affected the company's security over the years. Briefly with a name change and a CUSIP change the company was able to shake the short sellers off. Moreover, as evidenced by the ongoing litigation in Toronto Canada where amongst other things the company's previous agents are seeking an injunction against the stock bashers and a blog type web site Investors Hub that caters and harbours these individuals, which encourages factual company information to be removed or deleted while slanderous and erroneous self serving comments designed and crafted by short sellers with the sole intent to exploit the novice shareholders.

Aforementioned dividends # 2 and # 3 namely Sino Medica and Land Star were earned as a consulting fee by the company's Secretary Garr Winters for the benefit of MonArc Group while the company was engaged in the business of a USA based SPC company for the Chinese markets. It should be noted that investors qualifying for these various dividends can expect to receive dividends that will have a material value in relation to MonArc's current share price.

According to the company records, and notwithstanding various financing and recapitalizations the company undertook to acquire these assets and or interests in these assets, which are now being distributed to its shareholders in their entirety, the current actual share structure and float is exorbitant, extensive, and extravagantly, in favour of the company shareholders in comparison to what the market price currently reflects. The company is hopeful that these dividends once calculated and paid out will not only expose the activities of this blog web site and its dark propaganda machine which prays on the novice, and inexperienced shareholders, but will also rain in the short sellers and their activities which went on undetected for a prolonged period of time.

The company wishes to use this opportunity to advise its shareholders that in these currently depressed economic times, MONA remains a viable healthy company with good resources both financially and in human resources with its ITI Bio Tech company flourishing.


Investors seeking more information can contact The Investors Line, www.theinvestorsline.com Tel (860) 819-3746


Safe Harbour statement under the Private Securities Litigation Reform Act of 1995: Certain forward information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.


Get the Facts Right. The issuer works hard to continue to keep our shareholders informed, and news is updated frequently via Press Releases, Pink Sheet www.pinksheets.com filings, and updates to our websites. Other websites not sponsored, or recognized by the Company may provide misleading or disinformation to investors in order to manipulate trading patterns for a given stock. Always look for original content from trusted sources, rather than relying on 'excerpts' or discussion boards that may not give you the whole story. The Securities and Exchange Commission requires financial institutions or brokerage firms to provide their clients with documentation, describing the risks of investing in penny stocks.


CONTACT: For corporate matters contact: corporate@monacorporation.com


SOURCE MonArc Corporation (MONA)



Source: PR Newswire (February 6, 2009 - 12:28 PM EST)

News by QuoteMedia  

MonArc (MONA) Receives Unsolicited Interest in Acquisition of I.T.I. Biotech
Montreal Canada February 11, 2009. www.monacorporation.com The Issuer is publishing this “Supplemental Information Filing” to keep investors abreast of recent developments that may potentially have a material impact on operations.
The Issuer has been approached by a public company in the cosmetic/pharmaceutical sector expressing interest in acquiring MonArc’s I.T.I. Biotech subsidiary. The Issuer will be exploring this opportunity in greater detail and advise its shareholders of any definitive developments as they become available.
I.T.I. is a Bio‐Tech company, specializing in the manufacturing of products eliminating Airborne Volatile Organic Compounds (VOC’S). Products manufactured by ITI are laboratory tested, laboratory certified, biodegradable, food grade approved chemicals, natural scents. Using recyclable containers, perforated caps to ensure safety of children and pets and environmentally safe for the well being of the people and planet. It recently announced the launch of a new product that can neutralize and destroy airborne viruses, including the C‐Deficile virus. The issuers agents have been instructed to entertain offers that involve both cash and stock and not stock only.
In other Company news, the Company would like to advise its shareholders that the rescission of the Andrea Gold acquisition has not yet been completed. The Peruvian management has not yet returned shares issued in the original acquisition, together with the cash paid. It is uncertain what their current intentions are regarding the rescission. The Issuer will provide updates in line with any further developments. The company continues to work with authorities visa vie the payment of cash dividend and with other issuers for the stock which will be paid to its shareholders as a special dividend. The company reminds its shareholders not to rely on rumours that no dividends will be paid. In fact 5 separate and unique dividends will be paid out to its shareholders shortly. The company apologizes for the delay to its long term shareholders as it works out the details with governing bodies. Should the aforementioned buy out occur the management intends to pay part of those proceeds to its shareholders.
Safe Harbour statement under the Private Securities Litigation Reform Act of 1995: Certain forward information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.
Get the Facts Right. The issuer works hard to continue to keep our shareholders informed, and news is updated frequently via Press Releases, Pink Sheet www.pinksheets.com filings, and updates to our websites. Other websites not sponsored, or recognized by the Company may provide misleading or disinformation to investors in order to manipulate trading patterns for a given stock. Always look for original content from trusted sources, rather than relying on 'excerpts' or discussion boards that may not give you the whole story. The Securities and Exchange Commission requires financial institutions or brokerage firms to provide their clients with documentation, describing the risks of investing in penny stocks.
For corporate matters contact: corporate@monacorporation.com  

 

http://pinksheets.com/otciq/ajax/showFinancialReportById.pdf?id=19606  

MonArc Corporation (MONA) to Tackle Challenges to Assist Market Makers to File Form 211
MonArc Corporation is a publicly traded company listed on the Pink Sheets (MONA:PK). As stated in previous filings on the Pink Sheets, it is management's intentions to submit form 15c2-11s to allow Market Makers to establish a market for the Issuer's stock.
As noted in a letter previously posted as a supplementary filing posted on February 20, 2009 from McMullen and Associates, the Issuer's security lawyers, Market Makers have quite recently begun requiring additional disclosure not previously required, generally including audited financial statements as part of the submission requirements.
ITI Laval Bio Tech (ITI) is a Canadian based operating subsidiary of MONA. Because ITI has audited statements the company believes this should assist the process and meet the thresholds of obtaining the required status.
The Issuer is working with our legal counsel to try and accommodate these additional requirements, and will be making further announcements in our efforts to comply with these stiffer reporting requirements as we move forward against our objectives in this regard.
In other Company news, the Issuer is continuing to work with its Transfer Agent to execute the series of dividends previously announced. At this time, the Transfer Agent is working with the NASD and DTC to ensure that the allocation of the dividend proceeds can be accurately determined and allocated to the correct qualified shareholders. We hope to have more definitive updates shortly.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Certain information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.
Get the Facts Right. The issuer works hard to continue to keep our shareholders informed, and news is updated frequently via Press Releases, Pink Sheet http://www.pinksheets.com/ filings, and updates to our websites. Other websites not sponsored, or recognized by the Company may provide misleading or disinformation to investors in order to manipulate trading patterns for a given stock. Always look for original content from trusted sources, rather than relying on 'excerpts' or discussion boards that may not give you the whole story. The Securities and Exchange Commission requires financial institutions or brokerage firms to provide their clients with documentation, describing the risks of investing in penny stocks.
CONTACT: corporate@monacorporation.com  

http://www.pinksheets.com/otciq/ajax/...ancialReportById.pdf?id=19623  

MonArc Corp (MONA) I.T.I. Bio-Tech Announces Production of the FIRST EVER residential Air-Quality Meter.

MONTREAL, March 6, 2009 /PRNewswire-FirstCall via COMTEX/ -- www.monacorporation.com - The Company - (Pink Sheets:MONA) MONA Operating subsidiary ITI BioTech today after the markets closed announced the introduction of a revolutionary new product, Air-Stat. Air-Stat is a device that monitors the air quality in your home or office space, by showing a color bar and a digital display. It is the only residential air quality meter of its kind. It also monitors the humidity degree and the temperature in C degrees or degrees F. It will be available to the retail market for under a hundred dollars, the closest comparable device costing in the thousands.
This product is highly recommended for every household and individual office space.

"The Air-Stat will effectively identify allergens and contaminants in the air thereby increasing the quality of life for the millions of asthmatics and hyper-allergics worldwide. We will be meeting with health officials in the near future to discuss government subsidies in order to make sure that all the individuals that will benefit from our device will have one in their home. It is estimated there are over 35 million asthma sufferers in North America," stated Paul Sylvestre, President of I.T.I. Bio-Tech.

About I.T.I. Bio-Tech,

ITI is a Bio-Tech company, specializing in the manufacturing of products Eliminating Airborne VOC's. Products manufactured by ITI are laboratory tested, laboratory certified, biodegradable, food grade approved chemicals, natural scents. Using recyclable containers, perforated caps to ensure safety of children and pets and environmentally safe for the well-being of the people and planet.

Disclaimer:

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking statements," which are related to future, not past, events. Any such forward-looking statements are not assurances of future performance and involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. These risks and uncertainties include, among other things, (a) general economic and (b) our cost of financing, (c) our ability to complete acquisitions and dispositions and the risks associated therewith, and (d) our ability to retain key personnel. These factors, as well as additional factors, could affect our forward-looking statements. We urge you to carefully consider this information. We undertake no duty to update our forward-looking statements, including our earnings outlook.

CONTACT: corporate@monacorporation.com

SOURCE MonArc Corporation (MONA)



www.prnewswire.com  

http://www.nuayre.com/  

super Link. Die bauen ja erst an ihrer Homepage. Und MONA steht bei 0,0001 !!!
Wollt ihr nur die User hier verarschen ?
Das ganze Konstrukt ist doch nur ein Fake.  

Ob es fake ist oder nicht muss jeder für sich selbst entscheiden.  Hier werden nur Infos zu MONA zusammengetragen. Nicht mehr und nicht weniger.  

ihr könnt überhaupt kein englisch ! Sonst würdet ihr merken, dass hier nur eine Austrickserei der Aktionäre stattfindet.
The Company (MONA) has been receiving a very high volume of investor enquiries regarding the status of dividends that have been previously announced. Investors should note that all of the dividends previously announced are still forthcoming, but there have been unforeseen delays in processing and executing the distribution of these dividends, which are beyond the control of the company.

Und was hat der Aktionär davon ?  

hab mich schon gewundert was die Leute wärend meiner 2 Jahre in den USA für ne komische Sprache gesprochen haben und ich kein Wort verstanden habe....*grins*
Ne mal im ernst colea, wir stellen hier nur Meldungen von Mona rein, die über den Ticker kommen. Sonst nix !!
Und was der Aktionär davon hat??? Nun, er kann sich, soweit der englischen Sprache mächtig, sein eigenes Bild davon machen um was es hier geht.
Und wenn mich anhand der eingestellten Meldungen user wie jocyx als pusher hinstellen, bezweifele ich das DIE englisch können oder einfach nur den IQ eines gelutschen Drops haben. Also nochmal zum mitschreiben, ich poste nur Meldungen die vom Unternehmen selbst kommen oder damit zu tun haben, keinerlei Kaufs oder Verkaufsempfehlungen.  

I.T.I. Bio-Tech to seek FDA and Health Canada Approval for X10 Anti-Viral, Anti-Mold & Mildew Product!

MONTREAL, March 9, 2009 /PRNewswire-FirstCall via COMTEX/ -- www.monacorporation.com - The Company -- (Pink Sheets:MONA) MONA Operating subsidiary ITI BioTech today announced that it will seek approval from the FDA, Health Canada, as well as ECO Logo, which is the international standard, for its X10 product. "We are proud to announce that our revolutionary product, the X10, which has proven in all laboratory and clinical tests to be the only defense against many airborne viruses, and can effectively eradicate the growth and contamination of mold and mildew, will seek FDA and Health Canada approval, and we will simultaneously submit for approval to Eco-Logo which is the new worldwide standard for biological products. We are completely confident that all will proceed quickly and will give us a worldwide market to sell our products to," stated Paul Sylvestre, President of I.T.I. Bio-Tech.
About I.T.I. Bio-Tech

ITI is a Bio-Tech company, specializing in the manufacturing of products Eliminating Airborne VOC'S. Products manufactured by ITI are laboratory tested, laboratory certified, biodegradable, food grade approved chemicals, natural scents. Using recyclable containers, perforated caps to ensure safety of children and pets and environmentally safe for the well-being of the people and planet.

Disclaimer:

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking statements", which are related to future, not past, events. Any such forward-looking statements are not assurances of future performance and involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. These risks and uncertainties include, among other things,(a) general economic and (b) our cost of financing, (c) our ability to complete acquisitions and dispositions and the risks associated therewith, and (d) our ability to retain key personnel. These factors, as well as additional factors, could affect our forward-looking statements. We urge you to carefully consider this information. We undertake no duty to update our forward-looking statements, including our earnings outlook.

CONTACT: corporate@monacorporation.com

SOURCE MonArc Corporation (MONA)



www.prnewswire.com  

MonArc Corporation (MONA:PK) To Sell Its ITI Biotech Division
MONTREAL, March 19 /PRNewswire-FirstCall/ - Mon Arc Corporation (www.monacorporation.com - MONA.PK) today after the market closed announced that it has reached an agreement with a Bio Tech fully reporting Pink Sheet company to acquire 100% of ITI. The transaction valued at 2.5 million dollars will be completed on a cash and stock basis.

The deal will see MONA realize approximately a 2 million dollar net gain.

The transaction is set to close within the next 30 to 45 days.

In other corporate updates, the management continues to work closely with the buyers of its previously announced asset sales and various transfer agents to sort out various cash and stock dividends which the company intends and expects to be in a position to distribute to its shareholders shortly.


Safe Harbour statement under the Private Securities Litigation Reform Act of 1995: Certain forward information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.

CONTACT: For corporate matters contact: corporate@monacorporation.com


SOURCE MonArc Corporation (MONA)



Source: PR Newswire (March 19, 2009 - 4:30 PM EDT)

News by QuoteMedia  

The deal will see MONA realize approximately a 2 million dollar net gain.
The transaction is set to close within the next 30 to 45 days.
Also schätzungsweise 2 Mill. Dollar; ob man wieder mit eigenen Aktien bezahlt ?
Auch hat man 30-45 Tage Schonfrist für Kritiker herausgeschunden.  

http://www.pinksheets.com/otciq/ajax/...ancialReportById.pdf?id=20122  

http://www.pinksheets.com/otciq/ajax/...ancialReportById.pdf?id=23396

Gibt es ab heute Parallelen zum Threadbeginn und Verlauf vom 02.09.2008 ? Damals starteten wir den Thread bei 0,001 US.

http://ih.advfn.com/...O%5EMONA&period=0&size=19&volume=1  

wann der handel in deutschland wieder beginnt, vielleícht morgen schon zu 0,001€ ?